Topical 5-fluorouracil for treatment of cervical intraepithelial neoplasia 2: A randomized controlled trial

American Journal of Obstetrics and Gynecology

Volumn 210, Issue 4, 2014, Pages 314.e1-314.e8

  Rahangdale, Lisa ^a   Lippmann, Quinn K ^a   Garcia, Katelyn ^b   Budwit, Debra ^a   Smith, Jennifer S ^b   Van Le, Linda ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

Author keywords

5 fluorouracil; cervical intraepithelial neoplasia; medical therapy

Indexed keywords

FLUOROURACIL;

ADULT; ANXIETY; APPLICATION SITE BURNING; APPLICATION SITE ERYTHEMA; APPLICATION SITE IRRITATION; APPLICATION SITE PAIN; APPLICATION SITE PRURITUS; ARTICLE; BLEEDING; COLPOSCOPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN TISSUE; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PAPANICOLAOU TEST; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; RISK FACTOR; SKIN DEFECT; ULCER; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; YOUNG ADULT;

5-FLUOROURACIL; CERVICAL INTRAEPITHELIAL NEOPLASIA; MEDICAL THERAPY;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; FLUOROURACIL; HUMANS; OFF-LABEL USE; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84897387817     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.12.042     Document Type: Article

References (27)

1. D. Saslow, D. Solomon, and H.W. Lawson et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for prevention and early detection of cervical cancer J Low Genit Tract Dis 16 2012 175 204
2. US Preventative Task Force. Screening for cervical cancer: clinical summary of US Preventative Task Force recommendation. Available at: http://www.uspreventiveservicestaskforce.org/uspstf11/cervcancer/cervcancerrs. htm-summary. Accessed April 2, 2012.
3. American College of Obstetricians and Gyncologists Screening for cervical cancer. ACOG Practice bulletin no. 131 Obstet Gynecol 120 2012 1222 1238
4. D.I. Gonzalez Jr., C.M. Zhan, M.G. Retzloff, W.F. Moore, E.R. Kost, and R.R. Snyder Recurrence of dysplasia after loop electrosurgical excision procedures with long-term follow-up Am J Obstet Gynecol 184 2001 315 321
5. K.D. Sjoborg, I. Vistad, and S.S. Myhr et al. Pregnancy outcome after cervical cone excision: a case-control study Acta Obstet Gynecol Scand 86 2007 423 428
6. B. Noehr, A. Jensen, K. Fredricksen, A. Tabor, and S.K. Kjaar Loop electrosurgical excision of the cervix and subsequent risk for spontaneous preterm delivery: a population-based study of singleton deliveries during a 9-year period Am J Obstet Gynecol 201 2007 e1 e6
7. E. Stockfleth, H. Beti, and R. Orasan et al. Topical polyphenon E in the treatment of external genital and perinanal warts: a randomized controlled trial Br J Dermatol 158 2008 1329 1338
8. S.M. Garland, R. Waddell, A. Mindel, I.M. Denham, and J.C. McCloskey An open-label phase pilot study investigating optimal duration of imiquimod 5% cream for the treatment of external genital warts in women Int J STD AIDS 17 2006 448 452
9. S. Kola, and J.C. Walsh Patients' psychological reactions to colposcopy and LLETZ treatment for cervical intraepithelial neoplasia Eur J Obstet Gynecol Reprod Biol 146 2009 96 99
10. P.P. Martin-Hirsch, S.L. Keep, and A. Bryant Interventions for preventing blood loss during the treatment of cervical intraepithelial neoplasia Cochrane Database Syst Rev 16 2010 CD001421
11. D. Kruzikas, J.S. Smith, C. Harley, and P. Buzinec Costs associated with management of cervical human papillomavirus-related conditions Cancer Epidemiol Biomarkers Prev 21 2012 1469 1478
12. A.G. Ostor Natural history of cervical intraepithelial neoplasia: a critical review Int J Gynecol Pathol 12 1993 186 192
13. J.K. Chan, B.J. Monk, and C. Brewer et al. HPV infection and the number of lifetime sexual partners are strong predictor for 'natural' regression of CIN 2 and 3 Br J Cancer 15 2003 1062 1066
14. P.E. Castle, M. Schiffman, C.M. Wheeller, and D. Solomon Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2 Obstet Gynecol 113 2009 18 25
15. H. Ashton, G.W. Beveridge, and C.J. Stevenson Topical treatment of skin tumours with 5-fluorouracil Br J Dermatol 82 1970 207 209
16. M. Stanley Chapter 17: genital human papillomavirus infections - current and prospective therapies J Natl Cancer Inst Monogr 31 2003 117 124
17. H.P. van de Nieuwenhof, I.A.M. van der Avoort, and J.A. de Hullu Review of squamous premalignant vulvar lesions Crit Rev Oncol Hematol 68 2008 131 156
18. H.B. Krebs, and B.F. Helmkamp Chronic ulcerations following topical therapy with 5-fluorouracil for vaginal human papillomavirus-associated lesions Obstet Gynecol 38 1991 250 258
19. T.A. Syed, Z.A. Quereshi, S.A. Ahmad, and S.M. Ali Management of intravaginal warts in women with 5-flourouracil (1%) in vaginal hydrophilic gel: a placebo-controlled double-blind study Int J STD AIDS 11 2000 371 374
20. H.B. Krebs Prophylactic topical 5-fluorouracil following treatment of human papillomavirus-associated lesions of the vulva and vagina Obstet Gynecol 68 1986 837 841
21. M. Maiman, D.H. Watts, J. Andersen, P. Clax, M. Merino, and M.A. Kendall Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: a randomized trial Obstet Gynecol 94 1999 954 961
22. Food and Drug Administration. Efudex topical solutions and cream. 2005. Available at: http://www.accessdata.fda.gov/drugsatfda-docs/label/2005/ 016831s049lbl.pdf. Accessed Aug. 1, 2013.
23. L. Edwards, A. Ferenczy, and L. Eron et al. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human papilloma virus Arch Dermatol 134 1998 25 30
24. S. Tatti, J.M. Swinehart, C. Thielert, A. Mescheder, and K.R. Beutner Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial Obstet Gynecol 111 2008 1371 1379
25. National Institutes of Health. Division of AIDS. Table for grading the severity of adult and pediatric adverse events. 2004. Accessed Sept. 17, 2009.
26. C. Grimm, S. Polterauer, and C. Natter et al. Treatment of cervical intraepithelial neoplasia with topical imiquimod Obstet Gynecol 120 2012 152 159
27. C. Van Pachterbeke, D. Bucella, and S. Rozenberg et al. Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prosective, placebo-controlled study Gynecol Oncol 115 2009 69 74